AIGH Capital Management LLC In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), AIGH Capital Management LLC reported 39 stock positions worth $207.3 million . Its top holding was Scpharmaceuticals (SCPH) at 8.2% of the portfolio, followed by Ouster (OUST, 7.1% ) and Electrovaya (ELVA, 6.9% ). Compared with Q4 2023, it opened 15 new positions, sold out of 13, added to 10 and reduced 10. The biggest buy was Delcath Systems (DCTH, shares +100% ) and the biggest sale an exit from Aspen Aerogels (ASPN).
Location BALTIMORE, MD
CIK 0001835943
Portfolio Value $207.3M (Q1 2024) Holdings 39 stocks · $207.3M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2023 SCPH Scpharmaceuticals Inc. 8.21% 3,389,159 $17.0M Add +9.1% OUST Ouster Inc. 7.11% 1,857,114 $14.7M No change ELVA Electrovaya Inc. 6.94% 4,119,941 $14.4M Add +22.9% CLRB Cellectar Biosciences Inc. 5.38% 2,804,917 $11.2M Add +46.5% DCTH Delcath Systems Inc. 5.35% 2,359,728 $11.1M Add +99.6% MYO Myomo Inc. 4.42% 2,802,592 $9.2M Add +5.0% TELA Tela Bio Inc. 3.87% 1,415,255 $8.0M Add +2.7% HUMA Humacyte Inc. 3.23% 2,155,958 $6.7M New XAIR Beyond Air Inc. 3.12% 3,714,458 $6.5M New COYA Coya Therapeutics Inc. 3.11% 649,427 $6.4M Reduce -37.1% FENC Fennec Pharmaceuticals Inc. 3.06% 570,332 $6.3M Add +73.2% IPWR Ideal Power Inc. 3.00% 700,000 $6.2M Add +2371.6% EGRX Eagle Pharmaceuticals Inc. 3.00% 1,186,509 $6.2M New THTX Theratechnologies Inc. 2.97% 3,725,204 $6.2M Add +0.2% ALIM Alimera Sciences Inc. 2.86% 1,520,359 $5.9M Reduce -31.7% OSPN Onespan Inc. 2.80% 500,000 $5.8M New PROF Profound Medical Corp. 2.66% 646,733 $5.5M No change INFN Infinera Corp. 2.59% 889,284 $5.4M New IDN Intellicheck Inc. 2.54% 1,514,026 $5.3M New LPTH Lightpath Technologies Inc. Class A 2.35% 3,523,932 $4.9M Reduce -5.4% BKTI BK Technologies Corp. 2.33% 330,896 $4.8M No change IMMX Immix Biopharma Inc. 2.30% 1,555,000 $4.8M New BDSX Biodesix Inc. 2.29% 3,321,085 $4.7M Reduce -28.7% RCAT Red Cat Holdings Inc. 1.83% 4,964,873 $3.8M Reduce -1.2% APRE Aprea Therapeutics Inc. 1.69% 539,300 $3.5M Add +54.4% CGTX Cognition Therapeutics Inc. 1.67% 1,897,273 $3.5M Reduce -6.9% INAB IN8BIO Inc. 1.64% 2,874,962 $3.4M Reduce -29.9% ADVM Adverum Biotechnologies Inc. 1.11% 162,547 $2.3M New PYPD Polypid Ltd. 1.10% 479,246 $2.3M New CYBIN INC 0.89% 4,651,165 $1.9M New ACASTI PHARMA INC 0.82% 497,359 $1.7M New KPRX Kiora Pharmaceuticals Inc. 0.78% 2,300,000 $1.6M New ELUT Elutia Inc. 0.66% 436,566 $1.4M Reduce -74.3% BWAY Brainsway Ltd.-ADR 0.62% 242,936 $1.3M Reduce -76.6% FKWL Franklin Wireless Corp. 0.56% 390,000 $1.2M No change BFRI Biofrontera Inc. 0.37% 501,434 $766K New KWESST MICRO SYSTEMS INC 0.30% 501,915 $630K Reduce -9.8% EVOK Evoke Pharma Inc. 0.25% 846,564 $516K New VCNX Vaccinex Inc. 0.21% 58,365 $432K New
Options reported separately and not counted above: XBI puts ($94.9M), MU calls ($30.7M).
Other holdings (2): bonds, preferreds, convertibles and warrants · $120K (not counted above) Security Class Shares / Principal Value Change DFSCW Kwesst Micro Systems Inc.-27 *W EXP 09/01/202 598,500 $78K No change SVREW Saverone 2014 Ltd. -CW27 *W EXP 06/02/202 568,194 $43K No change
Total filed on the 13F, all lines: $207.5M.
Portfolio Sells Q4 2023 → Q1 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▲ ASPN Aspen Aerogels Inc. Sold out 0.00% −11.27 INDI Indie Semiconductor Inc. Class A Sold out 0.00% −7.24 TGAN Transphorm Inc. Sold out 0.00% −6.68 SPRB Spruce Biosciences Inc. Sold out 0.00% −2.46 LIVEPERSON INC Sold out 0.00% −2.42 APLT Applied Therapeutics Inc. Sold out 0.00% −2.20 APYX Apyx Medical Corp. Sold out 0.00% −2.12 BWAY Brainsway Ltd.-ADR Reduce -76.6% 0.62% −2.04 ABEO Abeona Therapeutics Inc. Sold out 0.00% −1.56 BDSX Biodesix Inc. Reduce -28.7% 2.29% −1.10 GSIT Gsi Technology Inc. Sold out 0.00% −0.99 VERU Veru Inc. Sold out 0.00% −0.98 ALIM Alimera Sciences Inc. Reduce -31.7% 2.86% −0.95 ADVM Adverum Biotechnologies Inc. Sold out 0.00% −0.95 ELUT Elutia Inc. Reduce -74.3% 0.66% −0.79 INAB IN8BIO Inc. Reduce -29.9% 1.64% −0.43 VACCINEX INC Sold out 0.00% −0.21 TFFP TFF Pharmaceuticals Inc. Sold out 0.00% −0.08 RCAT Red Cat Holdings Inc. Reduce -1.2% 1.83% +0.08 KWESST MICRO SYSTEMS INC Reduce -9.8% 0.30% +0.11 CGTX Cognition Therapeutics Inc. Reduce -6.9% 1.67% +0.17 COYA Coya Therapeutics Inc. Reduce -37.1% 3.11% +0.19 LPTH Lightpath Technologies Inc. Class A Reduce -5.4% 2.35% +0.49
Portfolio Buys Q4 2023 → Q1 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▼ DCTH Delcath Systems Inc. Add +99.6% 5.35% +3.40 CLRB Cellectar Biosciences Inc. Add +46.5% 5.38% +3.28 HUMA Humacyte Inc. New 3.23% +3.23 XAIR Beyond Air Inc. New 3.12% +3.12 EGRX Eagle Pharmaceuticals Inc. New 3.00% +3.00 IPWR Ideal Power Inc. Add +2371.6% 3.00% +2.92 ELVA Electrovaya Inc. Add +22.9% 6.94% +2.88 OSPN Onespan Inc. New 2.80% +2.80 INFN Infinera Corp. New 2.59% +2.59 IDN Intellicheck Inc. New 2.54% +2.54 IMMX Immix Biopharma Inc. New 2.30% +2.30 FENC Fennec Pharmaceuticals Inc. Add +73.2% 3.06% +1.60 ADVM Adverum Biotechnologies Inc. New 1.11% +1.11 PYPD Polypid Ltd. New 1.10% +1.10 APRE Aprea Therapeutics Inc. Add +54.4% 1.69% +1.04 CYBIN INC New 0.89% +0.89 ACASTI PHARMA INC New 0.82% +0.82 KPRX Kiora Pharmaceuticals Inc. New 0.78% +0.78 THTX Theratechnologies Inc. Add +0.2% 2.97% +0.58 SCPH Scpharmaceuticals Inc. Add +9.1% 8.21% +0.49 BFRI Biofrontera Inc. New 0.37% +0.37 TELA Tela Bio Inc. Add +2.7% 3.87% +0.26 EVOK Evoke Pharma Inc. New 0.25% +0.25 VCNX Vaccinex Inc. New 0.21% +0.21 MYO Myomo Inc. Add +5.0% 4.42% −0.87
Options Activity Q4 2023 → Q1 2024 Security Type Change vs Q4 2023 Underlying Shares Value ▼ XBI SS SPDR S&P Biotech ETF put New 1,000,000 $94.9M MU Micron Technology Inc. call New 260,000 $30.7M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 42 $1.1B SNDK, MXL, INTC, APPS, SIMO Q1 2026 40 $488.3M SNDK, TYGO, SIMO, ZBRA, LASR Q4 2025 31 $338.3M SNDK, CSTL, PSNL, LASR, DAWN Q3 2025 34 $285.6M SNDK, PSNL, HUCK, ARQ, MXL Q2 2025 34 $213.1M PSNL, HUCK, SCPH, ARQ, VPG Q1 2025 38 $192.7M VSTM, MYO, PSNL, ARQ, SCPH Q4 2024 36 $265.7M PSNL, MYO, ARQ, DCTH, MRVL Q3 2024 37 $213.6M PSNL, SCPH, ARQ, DCTH, APPS Q2 2024 35 $204.9M SIMO, INFN, DCTH, SCPH, ARQ Q1 2024 39 $207.3M SCPH, OUST, ELVA, CLRB, DCTH